INTRODUCTION
The Hedgehog signalling proteins act as key morphogens during the development of many organisms as diverse as flies and human (for review see Huangfu and Anderson, 2006; McMahon et al., 2003) . In most cases, HH proteins control cell proliferation, differentiation, migration and death in a dose-dependent fashion. In human, disruption of this pathway is associated with congenital abnormalities, and its inappropriate activation plays a central role in the initiation and progression of numerous forms of cancer (for review see Lau et al., 2006;  Pasca di Magliano and Hebrok, 2003) . HH exerts its influence on cells through a signalling cascade that ultimately regulates the expression of target genes that encode other signalling proteins such as Decapentaplegic (DPP)/TGFβ or Wingless (WG)/WNT, transcription factors such as Engrailed (EN) and the HH receptor Patched (PTC). These transcriptional effects are mediated by zinc finger transcription factors of the GLI family (such as Cubitus interruptus (CI) in fly), which have both repressing and activating functions (Alves et al., 1998; Aza et al., 1997; Motzny and Holmgren, 1995; Nguyen et al., 2005) . CI itself is found in at least three forms: a full length form (CI-FL), which is a transcriptional activator, a highly potent and labile activator form (CI-A) and a cleaved form (CI-R), which is a transcriptional repressor. A number of proteins are known to be involved in the control of CI, including the HH receptor PTC (a twelve-pass transmembrane protein) (Nakano et al., 1989 ) the seven-pass protein Smoothened (SMO) (Alcedo et al., 1996; van den Heuvel and Ingham, 1996 ) the kinesin-related protein Costal 2 (COS2) (Robbins et al., 1997; Sisson et al., 1997) , the Fbox/WD protein SLIMB (Jiang and Struhl, 1998) , a number of protein kinases (such as Fused (FU) (Preat et al., 1990) , the Protein Kinase A (PKA), the Casein Kinase I (CKI) and the Glycogen Synthase Kinase (GSK3) (for review see Price, 2006) ) and the pioneer protein Suppressor of Fused (SU(FU)) (Pham et al., 1995) .
In the absence of HH signal, the pathway is silenced at multiple levels ( for review see Hooper and Scott, 2005; Lum and Beachy, 2004) : (i) PTC inhibits SMO, which is endocytosed and undergoes degradation in the lysosome (Denef et al., 2000; Nakano et al., 2004; Zhu et al., 2003) ; (ii) CI-FL is sequestered in the cytoplasm by both SU(FU) (Methot and Basler, 2000) and microtubule-bound complexes containing FU and COS2 (Stegman et al., 2000; Wang and Jiang, 2004) , leading to its cleavage into CI-R in a proteasome-dependent fashion (Chen et al., 1999) . In contrast, in HH receiving cells, HH binding to PTC alleviates its negative effect on SMO, which becomes hyper-phosphorylated and stabilizes at the plasma membrane (Denef et al., 2000) . CI is then released from its cytoplasmic tethering, and its cleavage is inhibited, thus allowing it to transactivate HH target genes. Furthermore, in the cells exposed to the highest levels of HH, both FU and a positive input of COS2 promote formation of the highly potent CI-A form (Alves et al., 1998; Sanchez-Herrero et al., 1996; Wang and Holmgren, 2000) . SMO has several structural and functional characteristics in common with G proteincoupled receptors (GPCR), (Bockaert et al., 2004; Park et al., 2004) , such as the ability to interact with β-arrestin (reported in vertebrates only) (Chen et al., 2004) and probably the capacity to dimerize (Hooper, 2003) . Nevertheless, SMO displays some atypical features: it does not directly bind any known ligand, and no heterotrimeric G protein has been decisively implicated in the pathway. SMO activity is closely associated with vesicle trafficking, since its targeting to the plasma membrane is sufficient to activate the pathway and endocytosis from the membrane to the lysosome can shut it down (Denef et al., 2000; Nakano et al., 2004; Zhu et al., 2003) . Furthermore, SMO reportedly recruits the COS2/CI/FU cytoplasmic complex, probably via a direct interaction with COS2 (Jia et al., 2003; Lum et al., 2003; Ogden et al., 2003; Ruel et al., 2003) , suggesting that SMO could directly affect the activity of this complex.
Another positive key member of the HH pathway is the Ser-Thr protein kinase FU. In embryos, FU activity is necessary for the HH-dependent transcription of wg during segment polarity establishment (Preat et al., 1990) . In wing imaginal discs, it is required along the A/P boundary for the transcription of en (Alves et al., 1998; Sanchez-Herrero et al., 1996) and, to a lesser extent, of ptc and dpp (Glise et al., 2002; Lefers et al., 2001) . In all cases, FU antagonizes the negative effects of SU(FU), thus facilitating the entry of CI-FL into the nucleus and allowing its activation in CI-A (Methot and Basler, 2000; . It is composed of two domains: a N-terminal catalytic domain (called FU-KIN) and a C-terminal regulatory domain (called FU-REG) (Figure 1 ). FU itself is phosphorylated in response to HH stimulation (Therond et al., 1996b) and it can phosphorylate COS2 (Nybakken et al., 2002) and probably SU(FU) (Dussillol-Godar et al., 2006; Ho et al., 2005; Lum et al., 2003) , both of them interacting with FU-REG (Monnier et al., 1998; Monnier et al., 2002) . FU-REG is required for FU activity, but complex genetic interactions with su(fu) and cos2 indicate that it also participates in the down-regulation of the pathway in the absence of HH signal (Alves et al., 1998; Sanchez-Herrero et al., 1996) .
Here, we report that FU can interact directly with SMO in a HH-independent manner in vivo. Furthermore, a version of SMO that lacks its FU interaction domain can induce an ectopic constitutive up-regulation of HH target genes such as dpp, ptc and also en whose expression is characteristic of a high level of HH signalling. Finally, we show that this hyperactivity is independent from the presence of endogenous SMO but partially dependent on the endogenous activity of FU. All together, our data provide evidence of a new link between SMO and the HH-transducing protein complex and reveal a novel level of negative regulation of SMO that is likely mediated by its association with FU.
EXPERIMENTAL PROCEDURES

Plasmids:
pUAST-smo ΔFU was derived from pUAST-smo (containing a wild-type smo cDNA, A.M.
Voie and S. M. Cohen) as follows : unmethylated pUAST-smo was digested by XbaI, provoking a deletion from the 2718 th nucleotide to the end of the smo ORF, instead of which a PCR fragment including nucleotides 2718 to 2951 was cloned. As confirmed by sequencing, the resulting construct corresponds to a deletion from the 977 th codon to the end of smo ORF.
pAct5C-smo-EGFP, pAct5C-smoΔ FU -EGFP, pAct5C-mRFP-fu, pUAST-m6GFP-fu and pAct5C-mRFP-cos2-expression vectors were constructed by the Gateway recombination method (Invitrogen). The coding sequences (without the termination codon) of smo, fu and cos2 cDNAs were amplified by PCR, and cloned in the entry vector pENTR/D-TOPO by directional TOPO Cloning. The resulting plasmids were checked by sequencing. The destination vectors pAWG (pAct5C-GW-EGFP), pARW (pAct5C-mRFP-GW) (where GW is the recombination cassette) were built by T. Murphy and were a gift from him and pUASTnterm-m6GFP (pUAST-m6GFP-GW) was built and given by A. Brand. All cloning steps were performed according to the manufacturer's instructions. pDAhh was provided by S.
Cohen.
Yeast Two-Hybrid Cloning Analysis:
A cDNA fragment encoding the FU regulatory domain (aa 306 to 805) was cloned in the pB27 plasmid (Formstecher et al., 2005) , derived from the original pBTM116 (Vojtek and Hollenberg, 1995) . A random-primed cDNA library from Drosophila embryos (0-24 hours) poly(A + ) RNA was constructed into the pP6 plasmid derived from the original pGADGH (Bartel et al., 1993) . The library was transformed into the Y187 yeast strain and ten million independent yeast colonies were collected, pooled and stored at -80°C as equivalent aliquot fractions of the same library. The mating protocol has been described elsewhere (Rain et al., 2001 ). The screen was performed to ensure that a minimum of 50 million interactions were tested. The prey fragments from the positive clones were amplified by PCR and sequenced at their 5' and 3' junctions on a PE3700 Sequencer. The resulting sequences were used to identify the corresponding gene in the GenBank database (NCBI) by a fully automated procedure.
Cell culture and transfection:
Clone-8 (Cl8) cells were cultured as described in van Leeuwen et al. (van Leeuwen et al., 1994) . Cells were plated on concanavaline-coated cover glasses during 48h. We then carried out transient transfections using FlyFectin (OZ bioscience). After 24h incubation at 25°C, transfected cells were fixed 30 min with 4% paraformaldehyde.
For RNA interference, double stranded RNA was produced by in vitro transcription using T7 polymerase on a PCR product corresponding to residues 2983-3603 of cos2. PCR primers included the T7 promoter: 5' primer:
TAATACGACTCACTATAGGGCGAGTGGAAGGAGCGTGTTCTGTCC and 3' primer:
TAATACGACTCACTATAGGGCGTTTCGACGACTTGCGTCCTGGATAATTATCTTGT TCTTCTG). RNA interference was performed in S2 cells as described in Worby et al. (Worby et al., 2001 ) with minor modifications. Transfection of cells (Effectene reagent, Quiagen) with SMO-GFP and RFP-FU fusions was realized after two days and observation two days later.
Fly strains and genetics:
Flies were raised at 25°C. Mutants and transgenic strains are described in the following references: MS1096 (chr. X, (Capdevila et al., 1994) ), 71B (chr. III, (Brand and Perrimon, 1993) ), da-GAL4 (chr. III (Wodarz et al., 1995) (Therond et al., 1996a) .
Two UAS-GFP-smo strains were used: one (chr. II, used in Figures 2, 3, 4 and 6) was received from J. Jiang (Jia et al., 2003) , and the other (chr. III, used in Figures 5 and 3S ) was obtained by mobilization of the UAS-GFP-smo from a strain donated by A. Zhu (Zhu et al., 2003) and chosen for the stronger expression of the transgene than in the original strain (based on eye color and in situ GFP detection).
Transgenic, UAS-GFP-fu and UAS-smo  ΔFU strains were obtained following the standard Pelement-mediated procedure. The UAS-GFP-fu construct was validated by rescue of different fu mutants (Supplementary Data, Figure 1S ). Five UAS-smo  ΔFU strains were obtained, and they all induced a higher de-regulation of the pathway than the UAS-smo control strains. The same insertion (called T4-5F) was used in all figures. 
Imaginal discs immuno-staining:
Imaginal discs from third instar wandering larvae were dissected in PBS; fixed 30 min at room temperature (RT) in 4% paraformaldehyde, washed and permeabilized 3 times for 10 min in PBS + 0.3% Triton (PBST). They were incubated for one hour in PBST + 2% BSA and then overnight at 4°C with the primary antibody, washed 3 times for 10 min with PBST, blocked for 1 hour in PBST+ 2% BSA and incubated for 3 hours at RT with the secondary antibody (in PBST + 2% BSA). Finally, they were rinsed 3 times for 10 min in PBST before being mounted in Cytifluor. GFP was detected in disc merely fixed in parformaldehyde, without any detergent. 
Fluorescence imaging and analysis
All presented images of wing imaginal discs were acquired using a Leica-SP2-AOBS Cell culture images were acquired with a Yokogawa spinning disk confocal head coupled to a Leica inverted microscope (NA 1,4, objective 100x) (Leica, DMIRB). Excitation was achieved by using an Argon-Kripton RYB 75 mw Laser (Melles Griot). Images were acquired by using a CoolSnap HQ camera (pixel size 6.45 µm) (Princeton Instrument). The whole set up was driven by Metamorph 6.3 (Universal Imaging). The integration and wavelength switch module was designed by the firm "Errol" and the Institut Jacques Monod imaging facility.
Excitation and emission settings were selected as follows: GFP (ex: 488 nm, em: 495-525 nm), mRFP (ex: 568 nm, em : 580, 530).
We processed vesicle segmentation using ImageJ intensity threshold and edge detection functions.
To quantify the vesicular intensity fraction, the integrated intensity of vesicles was determined on each plane and the same procedure was used to determine total cytoplasmic fluorescence. Vesicular intensity fraction was obtained by calculating ratio of these two intensity values.
To determine the proportions of green, red and co-labelled vesicles, we used the ImageJ 
RESULTS AND DISCUSSION
SMO C-terminus interacts with FU regulatory domain.
The intracellular C-terminal tail of SMO (SMO-cytotail) has been previously shown to directly associate with COS2 and to co-immunoprecipitate FU, CI and, to a lesser extent, SU(FU) (Jia et al., 2003; Lum et al., 2003; Ogden et al., 2003; Ruel et al., 2003) . In a twohybrid screen using the last 500 amino acids of FU (amino acids (aa) 306 to 805, FU-REG) as a bait, one of the most frequently encountered partners corresponded to the SMO-cytotail.
Indeed, we identified 15 independent clones encoding SMO-cytotail ( Figure 1 ). In comparison, 25 independent clones were found to encode COS2 and only 3 SU(FU) (Formstecher et al., 2005 ; http://pim.hybrigenics.com/pimriderext/droso/index.html). All the SMO-encoding clones overlap and the smallest one defines a minimal region of SMO that is sufficient for its interaction with FU and corresponds to its last 52 amino acids (aa 985 to 1036).
Thus, our data show that the SMO C-terminus can interact directly with FU. This interaction almost certainly occurs independently of COS2 in yeast, since no cos2 homolog is present in this the genome of Saccharomyces cerevisiae.
Apical accumulation of SMO and FU in wing imaginal discs.
HH induces the stabilization of SMO and its relocalization from vesicles to the plasma membrane (Alcedo et al., 2000; Denef et al., 2000; Jia et al., 2003; Nakano et al., 2004; Zhu et al., 2003) . In wing imaginal discs, FU was reported to be mostly cytoplasmic (Methot and Basler, 2000) . Here, in order to compare the subcellular localizations of SMO and FU, we monitored each protein tagged with Green Fluorescent Protein (GFP) expressed (using MS1096 driver) in the columnar epithelium of the wing imaginal disc and in the salivary glands ( Figure 2 ). GFP fluorescence was directly observed after fixation of the disc, without treatment by detergents to ensure that any intracellular structures that might be sensitive to these latter were preserved. As expected, GFP-SMO was mostly present in vesicles and at the cell surface ( Figure 2B and 2C). Anterior and posterior vesicles may differ in nature since they seem to differ in size, with larger vesicles in the anterior region. Furthermore, comparing different sections throughout the imaginal disc revealed that these vesicles were more abundant in the apical region of the cells. This preferential accumulation of GFP-SMO at the apical region was confirmed by xz view reconstruction ( Figure 2D ). These results contrast with the accumulation of SMO at the baso-lateral surface reported by Denef et al. (Denef et al., 2000) . We checked the orientation of the discs by different methods (see Material and
Methods, Figure 2S in Supplementary Data and data not shown), and the same distribution was observed by immunodetection of endogenous SMO. Therefore, the discrepancy between our results and the published data is likely not due to the use of a fusion protein nor to overexpression conditions and is probably due to differences in the experimental conditions, either in the antibody or in the detergent used.
After checking that the UAS-GFP-fu construct was indeed able to rescue the effect of fu mutants (see Material and Methods and Figure 1S in supplementary data), we also monitored GFP-FU in wing discs. It preferentially accumulated in the anterior compartment (Figures 2E and 3A), as it was reported for endogenous FU (Ruel et al., 2003) . At the subcellular level, it was diffusely distributed in the cytoplasm and also accumulated both at the plasma membrane on the apical side and in scattered punctuate structures elsewhere in the cell (see xy sections
in Figure 2F and G and xz view reconstruction in Figure 2H ). In salivary glands, which are composed of large cells and have the capacity to respond properly to HH signal (Zhu et al., 2003) , GFP-FU had a similar distribution ( Figure 2I ). It was diffuse in the cytoplasm with a greater accumulation at the plasma membrane and in discrete puncta. Moreover, some accumulation was also seen in and around the nucleus, suggesting that FU might play a role in this compartment.
In conclusion, both SMO and FU proteins can be found in punctuate structures.
Furthermore, the enrichment of these FU or SMO structures in apical region of the cells likely reflects their polarized traffic towards the apical side where the extra-cellular HH signal is present.
FU and SMO co-localize in vivo
To better study SMO/FU co-localization, we pursued our analysis in transfected Cl8 cultured cells, whose size facilitates subcellular observations and which are capable of responding to the HH signal (Chen et al., 1999) . We transiently expressed FU tagged with the monomeric Red Fluorescent Protein (mRFP-FU) and SMO tagged with GFP (SMO-GFP), separately ( Figure 3D and E) or together ( Figure 3G -G"). Confirming the wing disc data, SMO alone accumulated in vesicles, while FU was present both diffusely in the cytoplasm and in small vesicle-like structures. We estimated that about 44% (+/-13%) of total FU intensity accumulated in these structures (see Table I ). We did not determine the nature of the FU-containing punctuate structures, but they probably correspond to vesicles, since (i)
published cell fractionation experiments have demonstrated that FU is indeed partially associated to the vesicular cytoplasmic pool (Ruel et al., 2003 , Stegman et al., 2004 , (ii) a large number of these structures also contain SMO (see below) which was shown to be vesicular (Nakano et al., 2004) and (iii) their distribution is affected by HH signal (to be published elsewhere).
FU co-expression did not significantly affect the localization of SMO. Conversely, while co-expression of SMO did not significantly change the intensity fraction of FU in vesicular structures (40% +/-14%, see Table I ), the FU-containing structures appeared to be fewer but larger ( Figure 3G ). According to the labelling profile ( Figure 3G "), we estimated ( Table I) that 53% of the vesicles were co-labelled with both proteins (SMO+ FU+, yellow arrow), while 25% of vesicles contained only SMO (SMO+ FU-, red arrow) and 22% only FU (SMO-FU+, green arrow). Furthermore, we analyzed the co-localization in SMO+ FU+ vesicles by determining the distribution profile correlation using Pearson Coefficient. We obtained a value of 0.845 ± 0.042 which, compared to the value of -0.062 ± -0.028 after randomization, shows a coherent distribution of both proteins and thus demonstrates their co-localization.
Next, we followed both GFP-FU (driven by MS1096) and endogenous SMO in the wing imaginal discs (Figure 3 A-C"). The small size of the cells and the use of detergent, which somewhat reduced the detection of punctate FU and SMO ( Figure 3B -C"), made subcellular analysis more difficult. Nevertheless, in the posterior compartment (where HH is present), a large number of GFP-FU vesicle structures co-localized with endogenous SMO ( Figure 3C -C"). In the anterior compartment where HH is absent, FU was also present in SMOcontaining vesicles, but due to a lesser accumulation of SMO, the signal was weaker (Figure 3 B-B").
In conclusion, in both cultured cells and wing imaginal discs, SMO and FU partially colocalize in vesicles. As shown for COS2/SMO association (Ogden et al., 2003) , colocalization of SMO/FU is not inhibited by HH (data not shown). The presence of FU in the vesicular structures lacking SMO might occur via COS2, since FU has been shown to interact and co-localize with COS2 (Monnier et al., 2002) , which can associate with membranes in a SMO-independent manner (Stegman et al., 2004) .
SMO controls FU subcellular localisation.
To examine the importance of the SMO/FU interaction in vivo, we designed a mutant of SMO (SMO ΔFU ) lacking its last 59 residues and thus its region of interaction with FU (see above).
In Cl8 cells, SMO  ΔFU tagged with GFP is mostly vesicular ( Figure 3F ), and its localization was unaffected by FU over-expression, like wild-type SMO. In contrast, SMO ΔFU overexpression leads to a decrease in the fraction of vesicular FU intensity to 10% (± 7%) of total FU intensity (Table 1 and Figure 3H ). This reduction indicates that SMO ΔFU can affect FU in a dominant negative fashion, probably by impeding its recruitment by endogenous SMO.
Such an effect might reflect a dimerization between SMO ΔFU and the endogenous wild-type SMO proteins, since it was previously suggested that SMO could homodimerize (Hooper, 2003) . Alternatively, it might be due to the titration of a third partner that is possibly ) that is sufficient to allow co-immunoprecipitation of COS2 (Jia et al., 2003) , although this latter interaction was not shown to be direct. We expressed mRFP-COS2 alone or with either SMO-GFP or SMO ΔFU -GFP in Cl8 cells (see Supplementary data, Figure   3S ). In all cases, mRFP-COS2 was present in punctate structures, but did not co-localize with SMO (or with SMO It is clear that multiple interactions can take place between the SMO, FU and COS2
proteins (Jia et al., 2003; Lum et al., 2003 ; Monnier et al., 1998; Monnier et al., 2002; Ogden et al., 2003; Sisson et al., 1997) . Although such multiple associations might simply play an architectural role in reinforcing the stability of the complex, it is also possible that each interaction plays a specific role. We assessed the functional relevance of SMO/FU interaction in vivo by comparing the effects of SMO and SMO ΔFU over-expression on wing development.
We used two drivers MS1096 and 71B, the latter also being broadly expressed, albeit at a Normally, in HH-receiving cells at the A/P boundary, CI-FL accumulates and induces expression of dpp, ptc and en, whereas in the anterior part of the wing pouch, CI-R represses dpp and hh (Methot and Basler, 1999) . Here, in response to over-expression of SMO ΔFU (driven by MS1096), high levels of ectopic expression of dpp as well as ptc were seen in most of the anterior part of the wing pouch, which is itself greatly enlarged ( Figure 6B to B''). In contrast, as previously reported (Hooper, 2003; Jia et al., 2004; Nakano et al., 1989 ) , overexpression of wild type SMO led to only low levels of ectopic expression of dpp in the most anterior region of the wing pouch, and had little effect on the expression of ptc ( Figure 6A ) was shown to have an activity comparable to that of wild type SMO (Nakano et al., 2004) . Two regions of the SMO cytotail are thus defined: (i) a region that covers the last 59 amino acids which interacts with FU and inhibits SMO activity in the absence of HH, and (ii) a region that includes amino acids 939 to 977 which is necessary for SMO ΔFU hyperactivity. None of these regions are required for the activity of full length SMO in response to HH.
In summary, our data show that the last 59 amino acids of SMO can inhibit its activity in the absence of HH signal. Since SMO ΔFU has lost its capacity to interact directly with FU. We propose that this negative regulation of SMO might occur via its association with FU-REG. In this context, the weakness of wild type SMO over-expression effects can be attributed to its negative control by endogenous FU. Note that such an effect might also partially account for previous genetic data showing that FU-REG can negatively regulate the HH pathway (Sanchez-Herrero et al., 1996 , Alves et al., 1998 , Lefers et al., 2001 , Ascano et al., 2002 .We cannot exclude, however, that the loss of the last 59 amino acids of SMO could lead to SMO hyperactivity independently from the loss of FU binding..
Partial requirement of FU for SMO
ΔFU -induced activation of the HH pathway.
FU thus seems to be a negative regulator of SMO in the absence of HH signal, but extensive genetic and molecular analysis has established a clear positive regulatory role for FU as well (Alves et al., 1998; Preat et al., 1990; Preat et al., 1993) . We assessed the participation of FU in the activating effects of SMO ΔFU and SMO, by over-expressing these latter in a fu mutant background. fu wings display a longitudinal fusion of the LV3 and LV4 associated with a posterior expansion of the double row of marginal bristles (Therond et al., 1996b ) ( Figure 7A ). We first tested the effects of fu RX2 , a fu allele lacking the last 57 codons of the fu coding sequence (Robbins et al., 1997) . Strikingly, the phenotype induced by either SMO ΔFU or SMO over-expression are suppressed in fu RX2 flies (Figure 7 , compare C with B and F with E). This effect is dosage dependent since the loss of one dose of fu is sufficient to reduce the SMO ΔFU -or SMO-induced phenotype ( Figure 7D ). At the A/P boundary, however, the LV3-4 spacing is normal, indicating that, in this region, expression of SMO ΔFU and SMO can still activate the pathway at a level sufficient to compensate for the effects of the fu mutation ( Figure 6 , compare C and F with A). All these reciprocal suppressive effects are not specific to the fu allele: similar results (See Supplementary data, Figure 5S and data not shown) were seen both with fu M1 ,which encodes only the first 80 amino acids of FU and is therefore unlikely to have a residual kinase activity, and with fu 1 , which has a missense mutation in the kinase domain of FU (Alves et al., 1998; Robbins et al., 1997) .
The suppression of the SMO or SMO ΔFU -induced phenotypes in the fu mutants argues that FU is required for SMO or SMO ΔFU effects on the HH pathway away from the A/P border, while the reciprocal suppression of the fu phenotype at the A/P boundary by overexpression of SMO or SMO ΔFU argues that , when high levels of HH are present, a high level of activation can occur without FU. Thus, SMO ΔFU and to a lesser extent, SMO, activate the HH pathway in both a FU-dependent and a FU-independent manner. Although, the requirement for FU seems normally restricted to the AP border (where HH levels are highest) for the expression of genes such as en, the present data indicate that FU can also be necessary for ectopic activation of the pathway away from the AP border. We propose that FU's normal role is to enhance the level of activation of the pathway in response to HH and that it also does so in presence of high levels of SMO or SMO
ΔFU
. The loss of FU activity combined with the activating effects of SMO or SMO ΔFU over-expression result a wild type phenotype.
Lastly, our data also show that, in the absence of FU, SMO can be as potent an activator as SMO 
CONCLUSION
HH signal appears to act mainly by alleviating or bypassing multiple inhibiting processes that stringently shut down the pathway in the absence of an adequate signal. This occurs through the tight control of the subcellular localization, composition and stability of protein complexes that link the transmembrane protein SMO to the regulators of the transcription factor CI. Here we report that SMO and FU can physically interact, leading to the direct recruitment of FU in SMO-containing vesicles in the absence of HH signal. The deletion of the region of the SMO cytotail required for its interaction with FU leads to a constitutive activation of the pathway.
Thus, our data suggest that FU, in addition to its known activator function, can also act as a negative regulator of SMO activity in the absence of HH signal (see the model in Figure 8 ).
Given that SMO activation by HH is known to involve both its hyperphosphorylation by PKA and CKI and changes in its traffic that lead to its stabilization, FU might inhibit SMO activation by acting on either of these stages. Via its dual role, FU may thus not only increase the robustness of the pathway, dampening any noise that might occur in the absence of any signal, but also reinforce the bistable switch properties of the pathway (Lai et al., 2004) . Chamot for sharing their expertise in fluorescent imaging, to R. Karess, H. Tricoire, and R.
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Confocal images of wing imaginal discs (A-H) or salivary glands (I) of MS1096; UAS-GFP-smo (A-D) or MS1096; UAS-GFP-fu flies (E-I).
(A) As reported for endogenous SMO and also shown in Figure 3A ', GFP-SMO is preferentially stabilized in the posterior compartment. However, it also accumulates in the around the nucleus (as also described in wing disc by Methot and Basler (Methot and Basler, 2000) ).
All wing discs in this study are oriented with the anterior (Ant) to the left and the dorsal to the bottom. The A/P boundary is marked by an arrow head except in panel F and G, which are views of the anterior compartment. In all sections, scale bars equal 10 μm.
Note that MS1096 is expressed at a higher level in the dorsal domain of the wing pouch (A and E). comes from a dissected imago.
Folds (represented by a star) are frequently encountered in the posterior compartment, probably due to differences in the sizes of the ventral and dorsal sides of the wing blade that result from a differential expression of MS1096 (see Figure 2 ).
Wings over-expressing SMO are enlarged with a widening of the LV3-LV4 intervein typical of an activation of the HH pathway at the A/P. These effects are not visible here for SMO ΔFU, due to the strong morphogenetic defects of the entire wing, although they can be observed in the case of lower activation (see Figure 6 ).
Here and in Figure 7 , wings are oriented with the anterior to the top and the proximal end to the left. All pictures are confocal sections, except for E and F, which are epifluorescence images.
To better visualize the anterior end labelling, the contrast was increased in D-D''. Figure   5S ). In the absence of HH signal, SMO's activating effects are prevented by its endocytosis and targeting to the lysosome. We propose that the last 59 amino acids of SMO participate in its inhibition to reinforce the inactivated state of the pathway in the absence of signal. FU's negative effects might rely on SMO association with FU, which could thus phosphorylate SMO to modulate its trafficking and/or to prevent its phosphorylation by the PKA and CKI.
The detection of changes in SMO trafficking would require a better characterization of the vesicles containing the wild type or truncated forms of SMO.
In response to HH, the inhibitory effects of both PTC and FU would be alleviated, and SMO is activated. In this situation, FU acts as an effector of SMO and is required for full activation of CI. Note also that GFP-FU was preferentially accumulated in the anterior wing disc cells (see Figure 2A and 3A) as reported for the endogenous FU protein (Ruel et al., 2003) . 
